© 2020 MJH Life Sciences and HCPLive. All rights reserved.
July 22, 2020
The association of DAA treatment with mortality did not differ by sex in the cirrhosis group.
June 26, 2020
Low-level viremia was transiently detectable in 21 recipients in the early post-transplant period, but not after 14 days.
March 19, 2020
The approval of sofosbuvir and velpatasvir comes after a multicenter clinical trial confirmed the safety and efficacy of the treatment.
March 02, 2020
The US Preventive Services Task Force suggested that patients 18-79 years old should be screened regardless of known risk factors.
February 28, 2020
Younger hepatitis B patients had better odds at transplant-free survival after 6 months.
January 27, 2020
In a new study, investigators generate a global estimate for children with HCV infections in 249 countries and territories.
December 24, 2019
With a shortage of hearts available, investigators turn to HCV-positive donors to try to reduce wait times.
December 05, 2019
In a new trial, investigators find glecaprevir and pibrentasvir is safe to treatment HCV patients who failed treatment with an NS5A inhibitor.
October 31, 2019
At the annual ACG meeting, Carlos Romero-Marrero, MD and Mohammad Alomari, MD discuss what can be done to reduce the drug use rate for high risk patients.
October 30, 2019
Roberto Simons-Linares, MD, presents new data at the annual ACG meeting on the association between hepatitis viral infections and acute pancreatitis.